Cargando…

Avenanthramide C as a novel candidate to alleviate osteoarthritic pathogenesis

Osteoarthritis (OA) is a degenerative disorder that can result in the loss of articular cartilage. No effective treatment against OA is currently available. Thus, interest in natural health products to relieve OA symptoms is increasing. However, their qualities such as efficacy, toxicity, and mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Thanh-Tam, Song, Won-Hyun, Lee, Gyuseok, Kim, Hyung Seok, Park, Daeho, Huh, Yun Hyun, Ryu, Je-Hwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560463/
https://www.ncbi.nlm.nih.gov/pubmed/34488936
http://dx.doi.org/10.5483/BMBRep.2021.54.10.108
_version_ 1784592938919002112
author Tran, Thanh-Tam
Song, Won-Hyun
Lee, Gyuseok
Kim, Hyung Seok
Park, Daeho
Huh, Yun Hyun
Ryu, Je-Hwang
author_facet Tran, Thanh-Tam
Song, Won-Hyun
Lee, Gyuseok
Kim, Hyung Seok
Park, Daeho
Huh, Yun Hyun
Ryu, Je-Hwang
author_sort Tran, Thanh-Tam
collection PubMed
description Osteoarthritis (OA) is a degenerative disorder that can result in the loss of articular cartilage. No effective treatment against OA is currently available. Thus, interest in natural health products to relieve OA symptoms is increasing. However, their qualities such as efficacy, toxicity, and mechanism are poorly understood. In this study, we determined the efficacy of avenanthramide (Avn)-C extracted from oats as a promising candidate to prevent OA progression and its mechanism of action to prevent the expression of matrix-metalloproteinases (MMPs) in OA pathogenesis. Interleukin-1 beta (IL-1β), a proinflammatory cytokine as a main causing factor of cartilage destruction, was used to induce OA-like condition of chondrocytes in vitro. Avn-C restrained IL-1β-mediated expression and activity of MMPs, such as MMP-3, -12, and -13 in mouse articular chondrocytes. Moreover, Avn-C alleviated cartilage destruction in experimental OA mouse model induced by destabilization of the medial meniscus (DMM) surgery. However, Avn-C did not affect the expression of inflammatory mediators (Ptgs2 and Nos) or anabolic factors (Col2a1, Aggrecan, and Sox9), although expression levels of these genes were upregulated or downregulated by IL-1β, respectively. The inhibition of MMP expression by Avn-C in articular chondrocytes was mediated by p38 kinase and c-Jun N-terminal kinase (JNK) signaling, but not by ERK or NF-κB. Interestingly, Avn-C added with SB203580 and SP600125 as specific inhibitors of p38 kinase and JNK, respectively, enhanced its inhibitory effect on the expression of MMPs in IL-1β treated chondrocytes. Taken together, these results suggest that Avn-C is an effective candidate to prevent OA progression and a natural health product to relieve OA pathogenesis.
format Online
Article
Text
id pubmed-8560463
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-85604632021-11-12 Avenanthramide C as a novel candidate to alleviate osteoarthritic pathogenesis Tran, Thanh-Tam Song, Won-Hyun Lee, Gyuseok Kim, Hyung Seok Park, Daeho Huh, Yun Hyun Ryu, Je-Hwang BMB Rep Article Osteoarthritis (OA) is a degenerative disorder that can result in the loss of articular cartilage. No effective treatment against OA is currently available. Thus, interest in natural health products to relieve OA symptoms is increasing. However, their qualities such as efficacy, toxicity, and mechanism are poorly understood. In this study, we determined the efficacy of avenanthramide (Avn)-C extracted from oats as a promising candidate to prevent OA progression and its mechanism of action to prevent the expression of matrix-metalloproteinases (MMPs) in OA pathogenesis. Interleukin-1 beta (IL-1β), a proinflammatory cytokine as a main causing factor of cartilage destruction, was used to induce OA-like condition of chondrocytes in vitro. Avn-C restrained IL-1β-mediated expression and activity of MMPs, such as MMP-3, -12, and -13 in mouse articular chondrocytes. Moreover, Avn-C alleviated cartilage destruction in experimental OA mouse model induced by destabilization of the medial meniscus (DMM) surgery. However, Avn-C did not affect the expression of inflammatory mediators (Ptgs2 and Nos) or anabolic factors (Col2a1, Aggrecan, and Sox9), although expression levels of these genes were upregulated or downregulated by IL-1β, respectively. The inhibition of MMP expression by Avn-C in articular chondrocytes was mediated by p38 kinase and c-Jun N-terminal kinase (JNK) signaling, but not by ERK or NF-κB. Interestingly, Avn-C added with SB203580 and SP600125 as specific inhibitors of p38 kinase and JNK, respectively, enhanced its inhibitory effect on the expression of MMPs in IL-1β treated chondrocytes. Taken together, these results suggest that Avn-C is an effective candidate to prevent OA progression and a natural health product to relieve OA pathogenesis. Korean Society for Biochemistry and Molecular Biology 2021-10-31 2021-10-31 /pmc/articles/PMC8560463/ /pubmed/34488936 http://dx.doi.org/10.5483/BMBRep.2021.54.10.108 Text en Copyright © 2021 by the The Korean Society for Biochemistry and Molecular Biology https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Tran, Thanh-Tam
Song, Won-Hyun
Lee, Gyuseok
Kim, Hyung Seok
Park, Daeho
Huh, Yun Hyun
Ryu, Je-Hwang
Avenanthramide C as a novel candidate to alleviate osteoarthritic pathogenesis
title Avenanthramide C as a novel candidate to alleviate osteoarthritic pathogenesis
title_full Avenanthramide C as a novel candidate to alleviate osteoarthritic pathogenesis
title_fullStr Avenanthramide C as a novel candidate to alleviate osteoarthritic pathogenesis
title_full_unstemmed Avenanthramide C as a novel candidate to alleviate osteoarthritic pathogenesis
title_short Avenanthramide C as a novel candidate to alleviate osteoarthritic pathogenesis
title_sort avenanthramide c as a novel candidate to alleviate osteoarthritic pathogenesis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560463/
https://www.ncbi.nlm.nih.gov/pubmed/34488936
http://dx.doi.org/10.5483/BMBRep.2021.54.10.108
work_keys_str_mv AT tranthanhtam avenanthramidecasanovelcandidatetoalleviateosteoarthriticpathogenesis
AT songwonhyun avenanthramidecasanovelcandidatetoalleviateosteoarthriticpathogenesis
AT leegyuseok avenanthramidecasanovelcandidatetoalleviateosteoarthriticpathogenesis
AT kimhyungseok avenanthramidecasanovelcandidatetoalleviateosteoarthriticpathogenesis
AT parkdaeho avenanthramidecasanovelcandidatetoalleviateosteoarthriticpathogenesis
AT huhyunhyun avenanthramidecasanovelcandidatetoalleviateosteoarthriticpathogenesis
AT ryujehwang avenanthramidecasanovelcandidatetoalleviateosteoarthriticpathogenesis